Skip to content
healthcare.dev

Sumatriptan Succinate and Naproxen Sodium

NDC 44183-850, sumatriptan succinate and naproxen sodium, tablet, from Currax Pharmaceuticals LLC dba Cypress, Hawthorn, Macoven.

Product NDC
44183-850
Status
Listed
Labeler
Currax Pharmaceuticals LLC dba Cypress, Hawthorn, Macoven
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA AUTHORIZED GENERIC
Application
NDA021926
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/44183-850 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • SUMATRIPTAN SUCCINATE85 mg/1
  • NAPROXEN SODIUM500 mg/1

Pharmacologic classes

Anti-Inflammatory Agents, Non-Steroidal [CS]; Cyclooxygenase Inhibitors [MoA]; Nonsteroidal Anti-inflammatory Drug [EPC]; Serotonin 1b Receptor Agonists [MoA]; Serotonin 1d Receptor Agonists [MoA]; Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]

Package NDCNDC-11Package
44183-850-09441830850099 TABLET in 1 BOTTLE (44183-850-09)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/5762bbe6-bddf-495c-adf8-9096f98a3a9c

Use it

Look up 44183-850 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/44183-850 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 44183-850. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.